BackMinerva Neurosciences Overview
Minerva Neurosciences Inc

Minerva Neurosciences Target Price

Where could NERV trade next? Consensus target price: $10.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.54

Average Target Price

$10.00120.3% upside

1 analysts in the last 4 months

High: $10 | Low: $10

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-14JefferiesAndrew Tsai$10120.3% upsideOpen
2025-12-01Jefferies$510.1% upsideOpen
2024-08-07H.C. WainwrightDouglas Tsao$510.1% upsideOpen
2024-05-02H.C. WainwrightDouglas Tsao$754.2% upsideOpen

Minerva Neurosciences (NERV) FAQ

As of the most recent data, NERV shows a target price of $10. Scroll down for historical charts and peer comparison views.

If Minerva Neurosciences moved to the average analyst target of $10, shares would be roughly 120.3% higher than $4.54. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Minerva Neurosciences's earnings trajectory.

Besides this target price page, Stockcircle has Minerva Neurosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $10) with ownership activity and broader fundamentals.

Minerva Neurosciences's target price is $10; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.